Security
Autonomix Medical, Inc. Common Stock · AMIX
AMIXNASDAQCommon stockCurrentCIK 1617867Updated Oct 14, 2026
AMIX price & chart
Loading TradingView…
NASDAQ:AMIX on TradingView ↗In the news
Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules ↗
Recent filings
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Submission of Matters to a Vote of Security Holders
Items 5.02, 5.07, 9.01
424B3 filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
EFFECT filing
DEFA14A filing
Show 5 more recent filings
Financials
FY 2026 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2026 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2027 | Q1 2026 | Q1 2025 | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| AssetsUSD | 10,211,000Source | 11,952,000Source | 1,809,000Source | 7,932,000Source | — | 3,980,000Source | 8,997,000Source | — | 7,600,000Source | 9,806,000Source | 9,407,000Source |
| Property, Plant and Equipment, NetUSD | 20,000Source | 20,000Source | 14,000Source | 16,000Source | — | 16,000Source | 19,000Source | — | 19,000Source | 21,000Source | 16,000Source |
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 9,934,000Source | 11,823,000Source | — | 7,477,000Source | — | 3,460,000Source | 8,589,000Source | — | 7,004,000Source | 9,136,000Source | 8,608,000Source |
| Assets, CurrentUSD | 10,191,000Source | 11,932,000Source | 1,685,000Source | 7,893,000Source | — | 3,964,000Source | 8,978,000Source | — | 7,581,000Source | 9,609,000Source | 9,391,000Source |
| LIABILITIES AND EQUITY | |||||||||||
| LiabilitiesUSD | 1,650,000Source | 2,245,000Source | 7,404,000Source | 1,487,000Source | — | 818,000Source | 1,965,000Source | — | 1,705,000Source | 1,707,000Source | 1,779,000Source |
| Stockholders’ equity: | |||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | — | 0Source | 0Source | — | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 11,000Source | 2,000Source | 14,000Source | 6,000Source | — | 1,000Source | 4,000Source | — | 11,000Source | 2,000Source | 19,000Source |
| Additional Paid in CapitalUSD | 72,977,000Source | 56,892,000Source | 27,952,000Source | 67,606,000Source | — | 72,983,000Source | 60,744,000Source | — | 72,978,000Source | 58,476,000Source | 46,578,000Source |
| Retained Earnings (Accumulated Deficit)USD | -64,427,000Source | -47,187,000Source | -33,561,000Source | -61,167,000Source | — | -69,822,000Source | -53,716,000Source | — | -67,094,000Source | -50,379,000Source | -38,969,000Source |
| Stockholders' Equity Attributable to ParentUSD | 8,561,000Source | 9,707,000Source | -5,595,000Source | 6,445,000Source | 3,028,000Source | 3,162,000Source | 7,032,000Source | 5,289,000Source | 5,895,000Source | 8,099,000Source | 7,628,000Source |
| Liabilities and EquityUSD | 10,211,000Source | 11,952,000Source | 1,809,000Source | 7,932,000Source | — | 3,980,000Source | 8,997,000Source | — | 7,600,000Source | 9,806,000Source | 9,407,000Source |
| Current liabilities: | |||||||||||
| Liabilities, CurrentUSD | 1,650,000Source | 2,245,000Source | 973,000Source | 1,487,000Source | — | 818,000Source | 1,965,000Source | — | 1,705,000Source | 1,707,000Source | 777,000Source |
| Accounts Payable, CurrentUSD | 714,000Source | 232,000Source | 663,000Source | 842,000Source | — | 371,000Source | 815,000Source | — | 700,000Source | 676,000Source | 492,000Source |
| Additional Financial Items | |||||||||||
| Accrued Liabilities, CurrentUSD | 936,000Source | 881,000Source | 310,000Source | 645,000Source | — | 447,000Source | 1,150,000Source | — | 1,005,000Source | 1,031,000Source | 285,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 0Source | 306Source | — |
| Other Liabilities, Noncurrent | — | — | —Source | — | — | — | — | — | — | — | — |
| Long-term Debt | — | — | —Source | — | — | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2027 | Q1 2026 | FY 2026 | FY 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 3,000Source | 3,000Source | 12,000Source | 81,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 2,000Source | 388,000Source | 529,000Source | 618,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -3,544,000Source | -2,604,000Source | -12,282,000Source | -6,648,000Source |
| Cash flows from investing activities: | ||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | 0Source | -10,000Source | -19,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | 0Source | 10,000Source | 19,000Source |
| Cash flows from financing activities: | ||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 0Source | 2,057,000Source | 10,160,000Source | 14,410,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -3,544,000Source | -547,000Source | -2,132,000Source | 7,743,000Source |
| Additional Financial Items | ||||||||||
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | — | — | — | 0Source | — | — | — | — | — | -4,556,000Source |
| General and Administrative ExpenseUSD | — | — | 1,619,000Source | 1,703,000Source | 5,167,000Source | 1,662,000Source | 1,255,000Source | 1,828,000Source | 9,890,000Source | 5,249,000Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| InterestExpenseNonoperatingUSD | — | — | 0Source | 45,000Source | 0Source | 43,000Source | — | 0Source | 0Source | 79,000Source |
| Investment Income, InterestUSD | — | — | 82,000Source | 80,000Source | 83,000Source | 72,000Source | 42,000Source | 84,000Source | 319,000Source | 127,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -3,261,000Source | -2,712,000Source | -7,451,000Source | -2,807,000Source | -2,728,000Source | -3,337,000Source | -16,715,000Source | -15,426,000Source |
| Nonoperating Income (Expense)USD | — | — | 82,000Source | 35,000Source | 83,000Source | 29,000Source | 42,000Source | 84,000Source | 319,000Source | -3,396,000Source |
| Operating ExpensesUSD | — | — | 3,343,000Source | 2,747,000Source | 7,534,000Source | 2,836,000Source | 2,770,000Source | 3,421,000Source | 17,034,000Source | 12,030,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 0Source | 2,121,000Source | 0Source | 2,840,000Source |
income statement · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2027 | Q1 2026 | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Operating Income (Loss)USD | — | — | -3,343,000Source | -2,747,000Source | -7,534,000Source | -2,836,000Source | -2,770,000Source | -3,421,000Source | -17,034,000Source | -11,588,000Source | -12,030,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -3,261,000Source | -2,712,000Source | -7,451,000Source | -2,807,000Source | -2,728,000Source | -3,337,000Source | -16,715,000Source | -11,410,000Source | -15,426,000Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -3,261,000Source | -2,712,000Source | -7,451,000Source | -2,807,000Source | -2,728,000Source | -3,337,000Source | -16,715,000Source | -11,410,000Source | -15,426,000Source |
| Earnings Per Share, BasicUSD per share | — | — | — | — | — | — | -5.02Source | -22.69Source | -2.32Source | -6.46Source | -1.05Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | — | — | — | — | 543,685Source | 147,058Source | 7,216,757Source | 1,766,425Source | 14,626,282Source |
| Interest Expense (non-operating)USD | — | — | 0Source | 45,000Source | 0Source | 43,000Source | — | 0Source | 0Source | 176,000Source | 79,000Source |
| Additional Financial Items | |||||||||||
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | — | — | — | 0Source | — | — | — | — | — | 0Source | -4,556,000Source |
| General and Administrative ExpenseUSD | — | — | 1,619,000Source | 1,703,000Source | 5,167,000Source | 1,662,000Source | 1,255,000Source | 1,828,000Source | 9,890,000Source | 6,863,000Source | 5,249,000Source |
| Investment Income, InterestUSD | — | — | 82,000Source | 80,000Source | 83,000Source | 72,000Source | 42,000Source | 84,000Source | 319,000Source | 354,000Source | 127,000Source |
| Nonoperating Income (Expense)USD | — | — | 82,000Source | 35,000Source | 83,000Source | 29,000Source | 42,000Source | 84,000Source | 319,000Source | 178,000Source | -3,396,000Source |
| Operating ExpensesUSD | — | — | 3,343,000Source | 2,747,000Source | 7,534,000Source | 2,836,000Source | 2,770,000Source | 3,421,000Source | 17,034,000Source | 11,588,000Source | 12,030,000Source |
| Research and Development ExpenseUSD | — | — | 1,724,000Source | 1,044,000Source | 2,367,000Source | 1,174,000Source | 1,515,000Source | 1,593,000Source | 7,144,000Source | 4,725,000Source | 2,225,000Source |
| Interest Expense, Debt | — | — | — | —Source | — | — | — | — | — | — | — |